158 related articles for article (PubMed ID: 29883665)
1. Structural Characterization and Formulation Development of a Trivalent Equine Encephalitis Virus-Like Particle Vaccine Candidate.
Toprani VM; Cheng Y; Wahome N; Khasa H; Kueltzo LA; Schwartz RM; Middaugh CR; Joshi SB; Volkin DB
J Pharm Sci; 2018 Oct; 107(10):2544-2558. PubMed ID: 29883665
[TBL] [Abstract][Full Text] [Related]
2. Stability of virus-like particles of red-spotted grouper nervous necrosis virus in the aqueous state, and the vaccine potential of lyophilized particles.
Lan NT; Kim HJ; Han HJ; Lee DC; Kang BK; Han SY; Moon H; Kim HJ
Biologicals; 2018 Jan; 51():25-31. PubMed ID: 29174141
[TBL] [Abstract][Full Text] [Related]
3. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis.
Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE
Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598
[TBL] [Abstract][Full Text] [Related]
4. A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates.
Ko SY; Akahata W; Yang ES; Kong WP; Burke CW; Honnold SP; Nichols DK; Huang YS; Schieber GL; Carlton K; DaSilva L; Traina-Dorge V; Vanlandingham DL; Tsybovsky Y; Stephens T; Baxa U; Higgs S; Roy CJ; Glass PJ; Mascola JR; Nabel GJ; Rao SS
Sci Transl Med; 2019 May; 11(492):. PubMed ID: 31092692
[TBL] [Abstract][Full Text] [Related]
5. Virus-like particle formulation optimization by miniaturized high-throughput screening.
Mohr J; Chuan YP; Wu Y; Lua LH; Middelberg AP
Methods; 2013 May; 60(3):248-56. PubMed ID: 23639868
[TBL] [Abstract][Full Text] [Related]
6. Formulation and stabilization of recombinant protein based virus-like particle vaccines.
Jain NK; Sahni N; Kumru OS; Joshi SB; Volkin DB; Russell Middaugh C
Adv Drug Deliv Rev; 2015 Oct; 93():42-55. PubMed ID: 25451136
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the stability of enterovirus 71 virus-like particle.
Lin SY; Chung YC; Chiu HY; Chi WK; Chiang BL; Hu YC
J Biosci Bioeng; 2014 Mar; 117(3):366-71. PubMed ID: 24140131
[TBL] [Abstract][Full Text] [Related]
8. Current status and future directions of fish vaccines employing virus-like particles.
Jeong KH; Kim HJ; Kim HJ
Fish Shellfish Immunol; 2020 May; 100():49-57. PubMed ID: 32130976
[TBL] [Abstract][Full Text] [Related]
9. Immunogens of encephalitis viruses.
Roehrig JT
Vet Microbiol; 1993 Nov; 37(3-4):273-84. PubMed ID: 7509539
[TBL] [Abstract][Full Text] [Related]
10. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.
Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B
Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490
[TBL] [Abstract][Full Text] [Related]
11. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines.
Ferguson JA; Reeves WC; Hardy JL
Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275
[TBL] [Abstract][Full Text] [Related]
12. Development of high-throughput and high sensitivity capillary gel electrophoresis platform method for Western, Eastern, and Venezuelan equine encephalitis (WEVEE) virus like particles (VLPs) purity determination and characterization.
Gollapudi D; Wycuff DL; Schwartz RM; Cooper JW; Cheng KC
Electrophoresis; 2017 Oct; 38(20):2610-2621. PubMed ID: 28842921
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses.
Barber TL; Walton TE; Lewis KJ
Am J Vet Res; 1978 Apr; 39(4):621-5. PubMed ID: 646197
[TBL] [Abstract][Full Text] [Related]
14. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
15. Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions.
Kramer RM; Zeng Y; Sahni N; Kueltzo LA; Schwartz RM; Srivastava IK; Crane L; Joshi SB; Volkin DB; Middaugh CR
J Pharm Sci; 2013 Dec; 102(12):4305-14. PubMed ID: 24129946
[TBL] [Abstract][Full Text] [Related]
16. Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles.
Hu L; Trefethen JM; Zeng Y; Yee L; Ohtake S; Lechuga-Ballesteros D; Warfield KL; Aman MJ; Shulenin S; Unfer R; Enterlein SG; Truong-Le V; Volkin DB; Joshi SB; Middaugh CR
J Pharm Sci; 2011 Dec; 100(12):5156-73. PubMed ID: 21858822
[TBL] [Abstract][Full Text] [Related]
17. Peptide presentation on primate erythroparvovirus 1 virus-like particles: In vitro assembly, stability and immunological properties.
Del Carmen Morán-García A; Rivera-Toledo E; Echeverría O; Vázquez-Nin G; Gómez B; Bustos-Jaimes I
Virus Res; 2016 Sep; 224():12-8. PubMed ID: 27523978
[TBL] [Abstract][Full Text] [Related]
18. Cross-protective immunity between equine encephalomyelitis viruses in equids.
Walton TE; Jochim MM; Barber TL; Thompson LH
Am J Vet Res; 1989 Sep; 50(9):1442-6. PubMed ID: 2552875
[TBL] [Abstract][Full Text] [Related]
19. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
20. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
